HOME >> BIOLOGY >> NEWS
Differences in gene usage dramatically change bacteria's 'lifestyles'

St. Louis, Nov. 29, 2004 -- When and where a bacterium uses its DNA can be as important as what's in the DNA, according to researchers at Washington University School of Medicine in St. Louis.

Scientists found significant differences in two bacterial organisms' use of a gene linked to processes that govern a form of antibiotic resistance. The distinction alters the bacteria's "lifestyles," or their ability to survive in different environments.

Researchers say the finding shows that understanding such changes will likely help development of new treatments for disease-causing microorganisms.

"These differences in gene usage are harder to look for, but we're not going to understand these organisms fully unless we take into account this other dimension," says senior investigator Eduardo Groisman, Ph.D., professor of molecular microbiology and Howard Hughes Medical Institute investigator.

The study appears the week of Nov. 29 in the online edition of the Proceedings of the National Academy of Sciences and in print on Dec. 7.

One of the bacteria studied, Salmonella enterica, is a leading cause of food poisoning and illness related to animal husbandry. The other, Escherichia coli, can cause illness but more typically plays a beneficial role in the human digestive system.

The two are closely related genetically. Less than 20 percent of E. coli's genes are not found in Salmonella and just over 25 percent of Salmonella's genes lack counterparts in E. coli.

Groisman's research had previously focused on how differences in gene content made Salmonella a persistent source of illness. He identified several areas in the bacteria's DNA known as "pathogenicity islands" -- clusters of genes unique to Salmonella that help it cause illness.

When complete gene maps for both bacteria became available in recent years, his interests expanded to understanding how the bacteria might use identical genes differently.

Salmo
'"/>

Contact: Michael Purdy
purdym@wustl.edu
314-286-0122
Washington University School of Medicine
29-Nov-2004


Page: 1 2 3

Related biology news :

1. Photos reveal first tool usage in wild gorillas
2. Jefferson scientists patent dramatically improves
3. Growing nerve cells in 3-D dramatically affects gene expression
4. Plant size morphs dramatically as scientists tinker with outer layer
5. Lack of a key enzyme dramatically increases resistance to sepsis
6. Simple idea to dramatically improve dengue vaccinations
7. Moderate lifetime reductions in LDL cholesterol dramatically reduce risk of heart disease
8. Ownership of Southern forestland dramatically changing
9. UF Researcher: Global warming dramatically changed ancient forests
10. Caloric restriction wont dramatically extend life span in humans: UCLA research
11. New miniaturised chip dramatically reduces time taken for DNA analysis

Post Your Comments:
(Date:5/24/2013)... metastatic cancer , Cancer cells spread and grow ... Stimulation of the immune system can help to eliminate ... the immune system to ignore cancer cells. Regulatory T ... immune system response. In this issue of the ... Levy at Stanford University found that regulatory T cells ...
(Date:5/24/2013)... water scientists from around the world today issued a ... span of one or two generations, the majority of ... under the handicap of severe pressure on fresh water, ... no substitute. This handicap will be self-inflicted and is, ... to chronic underlying problems led by mismanagement and sent ...
(Date:5/23/2013)... Health at Emory University, along with partners at ... $4 million grant over four years to establish ... Exposome Research Center: Understanding Lifetime Exposures). The grant ... the United States. , The HERCULES Center ... Health Sciences (NIEHS) of the National Institutes of ...
Breaking Biology News(10 mins):JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
(Date:5/23/2013)... , May 23, 2013 PuraMed BioScience ... and marketer of over-the-counter (OTC) medicinal and healthcare ... opinion on the company based on low market ... , Non-Prescription, All Natural Product to Treat Migraine ... Outperforms #1 Prescription Competitor , Currently Available ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... inch wide and provide 15 mm travel range ... The small dimensions make these new positioners ... confined spaces. A vacuum rated version is also ... Drawings, specifications and datasheets can be found at: ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
(Date:5/23/2013)... 23, 2013 Z Trim Holdings, Inc. (OTC ... a variety of industries, announced that Chef ... at this year,s National Restaurant Association ("NRA") NRA Show, ... of the Research Chefs Association.  Chef Ryan spoke on ... the Bad and the Ugly," joining four other prestigious ...
Breaking Biology Technology:PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3
Cached News: